The Role of the IGF-I Receptor in Apoptosis

Vitamins and Hormones

Volumn 53, Issue C, 1997, Pages 65-98

  Baserga, Renato ^a   Resnicoff, Mariana ^a   D'Ambrosio, Consuelo ^a   Valentinis, Barbara ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C RECEPTOR;

ANIMAL; APOPTOSIS; CELL DIVISION; CELL TRANSFORMATION; GENETICS; HUMAN; MUTATION; NEOPLASM; PATHOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MUTATION; NEOPLASMS; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION;

EID: 0030629622     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(08)60704-9     Document Type: Article

References (124)

1. Aaronson S. Growth factors and cancer. Science 254 (1991) 1146-1153
2. Abraham D., Lange A.M., Yutanaviboonchai W., Trpis M., Dickerson J.W., Swenson B., and Eberhard M.L. Survival and development of larval Onchocerca volvulus in primate and rodent hosts. J. Parasitol. 79 (1993) 571-582
3. Araki E., Lipes M.A., Patti M.E., Bruning J.C., Haag III B., Johnson R.S., and Kahn C.R. Alternative pathway of insulin signalling in mice with targeted disruption of the IS-1 gene. Nature (London) 372 (1994) 186-190
4. Arteaga C.L. Interference of the IGF system as a strategy to inhibit breast cancer growth. Breast Cancer Res. Treat. 22 (1992) 101-106
5. Askew D.S., Ashmun R.A., Simmons B.C., and Cleveland J.L. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6 (1992) 1915-1922
6. Baker J., Liu J.-P., Robertson E.J., and Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 73 (1993) 73-82
7. Ballotti R., Lammers R., Scimeca J.C., Dull T., Schlessinger J., Ullrich A., and Van Obberghen E. Intermolecular transphosphorylation between insulin receptors and EGF-insulin receptor chimerae. EMBO J. 8 (1989) 3303-3309
8. Baltensperger K., Kozma L.M., Cherniack A.D., Klarlund J.K., Chawla A., Banerjee U., and Czech M.P. Binding of the ras activator son of sevenless to insulin receptor substrate-1 signaling complexes. Science 260 (1993) 1950-1952
9. Barone M.V., and Courtneidge S.A. Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src. Nature (London) 378 (1995) 509-512
10. Baserga R. Oncogenes and the strategy of growth factors. Cell 79 (1994) 927-930
11. Baserga R. The insulin-like growth factor 1 receptor: A key to tumor growth. Cancer Res. 55 (1995) 249-252
12. Baserga R., and Rubin R. Cell cycle and growth control. Crit. Rev. Eukaryotic Gene Expression 3 (1993) 47-61
13. Basu T., Warne P.H., and Downward J. Role of Shc in the activation of Ras in response to epidermal growth factor and nerve growth factor. Oncogene 8 (1994) 3483-3491
14. Bergmann U., Funatomi H., Yokoyama M., Beger H.G., and Korc M. Insulin-like growth factor I overexpression in human pancreatic cancer: Evidence for autocrine and paracrine roles. Cancer Res. 55 (1995) 2007-2011
15. Blenis J. Signal transduction via the MAP kinases: Proceed at your own RSK. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 5889-5892
16. Brooks P.G., Montgomery A.M.P., Rosenfeld M., et al. Integrin alpha/v beta/3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79 (1994) 1157-1164
17. Buckbinder L., Talbott R., Velasco-Miguel S., Takenaka I., Faha B., Seizinger B.R., and Kley N. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature (London) 377 (1995) 646-649
18. Burgaud J.-L., and Baserga R. Intracellular transactivation of the insulin-like growth factor I receptor by an epidermal growth factor receptor. Exp. Cell Res. 223 (1996) 412-419
19. Burgaud J.-L., Resnicoff M., and Baserga R. Mutant IGF-I receptors as dominant negatives for growth and transformation. Biochem. Biophys. Res. Commun. 214 (1995) 475-481
20. Buscher D., Hipskind R.A., Krautwald S., Reimann T., and Baccarini M. Ras-dependent and -independent pathways target the mitogen activated protein kinase network in macrophages. Mol. Cell. Biol. 15 (1995) 466-475
21. Cai H., Erhardt P., Szeberenyi J., Diaz-Meco M.T., Johansen T., Moscat J., and Cooper G.M. Hydrolysis of phosphatidylcholine is stimulated by ras proteins during mitogenic signal transduction. Mol. Cell. Biol. 12 (1992) 5329-5335
22. Chantry A. The kinase domain and membrane localization determine intracellular interactions between epidermal growth factor receptors. J. Biol. Chem. 270 (1995) 3068-3073
23. Chiasson B.J., Armstrong J.N., Hooper M.L., Murphy P.R., and Robertson H.A. The application of antisense technology to the brain: Some pitfalls. Cell. Mol. Neurobiol. 14 (1994) 507-521
24. Christophori G., Naik P., and Hanahan D. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature (London) 369 (1994) 414-418
25. Cleveland J.L., and Ihle J.N. Contenders in FasL/TNF death signaling. Cell 81 (1995) 479-482
26. Conlon M.A., Tomas F.M., Owens P.C., Wallace J.C., Howarth G.S., and Ballard F.J. Long R/3 insulin-like growth factor I (IGF-I) infusion stimulates organ growth but reduces plasma IGF-I, IGF-II and IGF binding protein concentrations in the guinea pig. J. Endocrinol. 146 (1995) 247-253
27. Coppola D., Ferber A., Miura M., Sell C., D'Ambrosio C., Rubin R., and Baserga R. A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol. Cell. Biol. 14 (1994) 4588-4595
28. D'Ambrosio C., Keller S.R., Morrione A., Lienhard G.E., Baserga R., and Surmacz E. Transforming potential of the insulin receptor substrate 1. Cell Growth Differ. 6 (1995) 557-562
29. D'Ambrosio C., Ferber A., Resnicoff M., and Baserga R. A soluble insulin-like growth factor 1 receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. Cancer Res. 56 (1996) 4013-4020
30. DeAngelis T., Ferber A., and Baserga R. The insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the platelet-derived growth factor receptor. J. Cell. Physiol. 164 (1995) 214-221
31. D'Mello S.R., Galli C., Ciotti T., and Calissano P. Induction of apoptosis in cerebellar granule neurons by low potassium: Inhibition of death by insulin-like growth factor I and cAMP. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 10989-10993
32. Evan G., Wyllie A., Gilbert C., Littlewood T., Land H., Brooks M., Waters C., Penn L., and Hancock D. Induction of apoptosis in fibroblasts by the c-myc protein. Cell 69 (1992) 119-125
33. Falco J.P., Taylor W.G., DiFiore P.P., Weissman B.E., and Aaronson S.A. Interaction of growth factors and retroviral oncogenes with mitogenic signal transduction pathways of Balb/MK keratinocytes. Oncogene 2 (1988) 573-578
34. Feinstein R., Kanety H., Papa M.Z., Lunenfeld B., and Karasik A. Tumor necrosis factor alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J. Biol. Chem. 268 (1993) 26055-26058
35. Fernandez P.A., Rotello R.J., Rangini Z., Doupe A., Drexler H.C.A., and Yuan J. Expression of a specific marker of avian programmed cell death in both apoptosis and necrosis. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8641-8645
36. Fisher D.E. Apoptosis in cancer therapy: Crossing the threshold. Cell 78 (1994) 539-542
37. Giles R.V., Spiller D.G., and Tidd D.M. Detection of ribonuclease H-generated mRNA fragments in human leukemia cells following reversible membrane permeabilization in the presence of antisense oligodeoxynucleotides. Antisense Res. Dev. 5 (1995) 23-31
38. Gluckman P., Klempt N., Guan J., Mallard C., Sirimanne E., Dragunow M., Klempt M., Singh K., Williams C., and Nikolics K. A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem. Biophys. Res. Commun. 182 (1992) 593-599
39. Gronborg M., Wulff B.S., Rasmussen J.S., Kjeldsen T., and Gammeltoft S. Structure-function relationship of the insulin-like growth factor I receptor tyrosine kinase. J. Biol. Chem. 268 (1993) 23435-23440
40. Guieysse A.L., Praseuth D., Grigoriev M., Harel-Bellan A., and Helene C. Oligonucleotide-directed switching of DNA polymeraes to a dead-end track. Biochemistry 34 (1995) 9193-9199
41. Harrington E.A., Bennett M.R., Fanidi A., and Evan G.I. C-myc induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 13 (1994) 3286-3295
42. Hayry P., Millarniemi M., Aavik E., Alatalo S., Aho P., Yilmaz S., Haisanen-Sokolowski A., Cozzone G., Jameson B.A., and Baserga R. Stable D-peptide analog on insulin-like growth factor 1 inhibits smooth mucle cell proliferation after carotid ballooning injury in the rat. FASEB J. 9 (1995) 1336-1344
43. Hill C.S., and Treisman R. Transcriptional regulation by extracellular signals: Mechanisms and specificity. Cell 80 (1995) 199-211
44. Hongo A., D'Ambrosio C., Miura M., Morrione A., and Baserga R. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor. Oncogene (1996) in press
45. Hotamisligil G.S., Murray D.L., Choy L.N., and Spiegelman B.M. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 4854-4858
46. Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., and Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF alpha and obesity-induced insulin resistance. Science 271 (1996) 665-668
47. Kalebic T., Tsokos M., and Helman L.J. In vivo treatment with antibody against the IGF-I receptor suppresses growth of human rhabdomyosarcoma and down regulates p34/cdc2. Cancer Res. 54 (1994) 5531-5534
48. Kaleko M., Rutter W.G., and Miller A.D. Overexpression of the human insulin-like growth factor 1 receptor promotes ligand-dependent neoplastic transformation. Mol. Cell. Biol. 10 (1990) 464-473
49. Kato H., Faria T.N., Stannard B., Roberts Jr. C.T., and LeRoith D. Role of the tyrosine kinase domain in signal transduction by the insulin-like growth factor 1 IGF-1 receptor. J. Biol. Chem. 268 (1993) 2655-2661
50. Keller S., and Lienhard G. Insulin signalling: The role of insulin receptor substrate 1. Trends Cell Biol. 4 (1994) 115-119
51. Kurita T., and Namiki H. Apoptotic cell death induced by serum and its prevention by thiols. J. Cell. Physiol. 161 (1994) 63-70
52. Lammers R., Gray A., Schlessinger J., and Ullrich A. Differential signalling potential of insulin- and IGF-I receptor cytoplasmic domain. EMBO J. 8 (1989) 1369-1375
53. Lammers R., Van Obberghen E., Ballotti R., Schlessinger J., and Ullrich A. Transphosphorylation as a possible mechanism for insulin and epidermal growth factor activation. J. Biol. Chem. 265 (1990) 16886-16890
54. Lange Yutanawiboonchai A.M., Scott W.P., and Abraham D. IL-4 and IL-5 dependent protective immunity to Onchocerca volvulus infective larvae in Balb/cBYJ mice. J. Immunol. 153 (1994) 205-221
55. Li S., Ferber A., Miura M., and Baserga R. Mitogenicity and transforming activity of the insulin-like growth factor I receptor with mutations in the tyrosine kinase domain. J. Biol. Chem. 269 (1994) 32558-32564
56. Li S., Resnicoff M., and Baserga R. Effect of mutations at serine 1280-1283 on the mitogenic and transforming activities of the insulin-like growth factor 1 receptor. J. Biol. Chem. 271 (1996) 12254-12260
57. Liu D., Zong C., and Wang L.H. Distinctive effects of the carboxyl-terminal sequence of the insulin-like growth factor I receptor on its signaling functions. J. Virol. 67 (1993) 6835-6840
58. Liu J.-P., Baker J., Perkins A.S., Robertson E.J., and Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (igf-1) and type 1 IGF receptor (igflr). Cell 75 (1993) 59-72
59. Long L., Rubin R., Baserga R., and Brodt P. Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor I receptor. Cancer Res. 55 (1995) 1006-1009
60. Lu K., Levine R.A., and Campisi J. C-ras-Ha gene expression is regulated by insulin or insulin-like growth factor and by epidermal growth factor in murine fibroblasts. Mol. Cell. Biol. 9 (1989) 3411-3417
61. Macaulay V.M. Insulin-like growth factors and cancer. Brt. J. Cancer 65 (1992) 311-320
62. Majno G., and Joris I. Apoptosis, oncosis and necrosis. Am. J. Pathol. 146 (1995) 3-15
63. Matuoka K., Shibasaki F., Shibata M., and Takenawa T. Ash/Grb2, a SH2/SH3-containing protein, couples to signaling for mitogenesis and cytoskeletal reorganization by EGF and PDGF. EMBO J. 12 (1993) 3467-3473
64. McCormick F. How receptors turn Ras on. Nature (London) 363 (1993) 15-16
65. McCubrey J.A., Stillman L.S., Mayhew M.W., Algate P.A., Dellow R.A., and Kaleko M. Growth promoting effects of insulin-like growth factor 1 (IGF-1) on hematopoietic cells: Overexpression of introduced IGF-1 receptor abrogates interleukin-3 dependency of murine factor dependent cells by ligand dependent mechanism. Blood 78 (1991) 921-929
66. Medema R.H., and Bos J.L. The role of p21 ras in receptor tyrosine kinase signaling. Crit. Rev. Oncogen. 4 (1993) 615-661
67. Miura M., Li S., and Baserga R. Effect of a mutation at tyrosine 950 of the insulin-like growth factor I receptor on the growth and transformation of cells. Cancer Res. 55 (1995) 663-667
68. Miura M., Surmacz E., Burgaud J.L., and Baserga R. Different effects on mitogenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor I receptor. J. Biol. Chem. 270 (1995) 22639-22644
69. Montgomery A.M.P., Reisfeld R.A., and Cheresh D.A. Integrin alpha/v beta/3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8856-8860
70. Morrione A., DeAngelis T., and Baserga R. Failure of the bovine papilloma virus to transform mouse embryo fibroblasts with a targeted disruption of the insulin-like growth factor I receptor gene. J. Virol. 69 (1995) 5300-5303
71. Myers M.J., Sun X.J., Cheatham B., Jachna B.R., Glasheen E.M., Backer J.M., and White M.F. IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3-kinase. Endocrinology 132 (1993) 1421-1430
72. Neuenschwander S., Roberts Jr. C.T., and LeRoith D. Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth factor 1 receptor antisense ribonucleic acid. Endocrinology 136 (1995) 4298-4303
73. Nicholson D.W., All A., Thornberry N.A., et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature (London) 376 (1995) 37-43
74. Ohmichi M., Matuoka K., Takenawa T., and Saltiel A.R. Growth factors differentially stimulate the phosphorylation of Shc proteins and their association with Grb2 in PC-12 pheochromocytoma cells. J. Biol. Chem. 269 (1994) 1143-1148
75. O'Neill T.J., Craparo A., and Gustafson T.A. Characterization of an interaction between insulin receptor substrate-1 and the insulin receptor by using the two-hybrid system. Mol. Cell. Biol. 14 (1994) 6433-6442
76. Pelicci G., Lanfrancone L., Grignani F., McGlade J., Cavallo F., Forni G., Nicoletti I., Grignani F., Pawson T., and Pelicci G. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70 (1992) 93-104
77. Peterson J.E., Jelinek T., Kaleko M., Siddle K., and Weber M.J. Phosphorylation and activation of the IGF-I receptor in src-transformed cells. J. Biol. Chem. 269 (1994) 27315-27321
78. Pietrzkowski Z., Lammers R., Carpenter G., Soderquist A.M., Limardo M., Phillips P.D., Ullrich A., and Baserga R. Constitutive expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor abrogates all requirements for exogenous growth factors. Cell Growth Differ. 3 (1992) 199-205
79. Pietrzkowski Z., Sell C., Lammers R., Ullrich A., and Baserga R. Roles of insulin-like growth factor 1 (IGF-I) and the IGF-I receptor in epidermal growth factor-stimulated growth of 3T3 cells. Mol. Cell. Biol. 12 (1992) 3883-3889
80. Pietrzkowski Z., Werniche D., Porcu P., Jameson B.A., and Baserga R. Inhibition of cellular proliferation by peptide analogues of insulin-like growth factor 1. Cancer Res. 52 (1992) 6447-6451
81. Prager D., Li H.L., Asa S., and Melmed S. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor receptor mutant. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 2181-2185
82. Pronk G.J., McGlade J., Pelicci G., Pawson T., and Bos J.L. Insulin-induced phosphorylation of the 46- and 52-kDa Shc proteins. J. Biol. Chem. 268 (1993) 5748-5753
83. Resnicoff M., Coppola D., Sell C., Rubin R., Ferrone S., and Baserga R. Growth inhibition of human melanoma cells in nude mice by antisensense strategies to the type 1 insulin-like growth factor receptor. Cancer Res. 54 (1994) 4848-4850
84. Resnicoff M., Sell C., Rubini M., Coppola D., Ambrose D., Baserga D., and Rubin R. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor I (IGF-I) receptor are non-tumorigenic and induce regression of wild-type tumors. Cancer Res. 54 (1994) 2218-2222
85. Resnicoff M., Abraham D., Yutanawiboonchai W., Rotman H., Kajstura J., Rubin R., Zoltick P., and Baserga R. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res. 55 (1995) 2463-2469
86. Resnicoff M., Burgaud J.-L., Rotman H.L., Abraham D., and Baserga R. Correlation between apoptosis, tumorigenesis and levels of insulin-like growth factor I receptors. Cancer Res. 55 (1995) 3739-3741
87. Rodriguez-Tarduchy G., Collins M.K.L., Garcia I., and Lopez-Rivas A. Insulin-like growth factor I inhibits apoptosis in IL-3 dependent hemopoietic cells. J. Immunol. 149 (1992) 535-540
88. Rogler C.E., Yang D., Rossetti L., Donohoe J., Alt E., Chang C.J., Rosenfeld R., Neely K., and Hintz R. Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor II transgenic mice. J. Biol. Chem. 269 (1994) 13779-13784
89. Rose D.W., Satiel A.R., Majumdar M., Decker S.J., and Olefsky J.M. Insulin receptor substrate 1 is required for insulin-mediated mitogenic signal transduction. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 797-801
90. Rubini M., Werner H., Gandini E., Roberts Jr. C.T., LeRoith D., and Baserga R. Platelet-derived growth factor increases the activity of the promoter of the insulin-like growth factor-1 (IGF-1) receptor gene. Exp. Cell Res. 211 (1994) 374-379
91. Ruoslahti E., and Reed J.C. Anchorage dependence, integrins, and apoptosis. Cell 77 (1994) 477-478
92. Sainio K., Saarma M., Nonclercq D., Paulin L., and Sariola H. Antisense inhibition of low-affinity nerve growth factor receptor in kidney cultures: Power and pitfalls. Cell. Mol. Neurobiol. 14 (1994) 439-457
93. Sakaue M., Botwell D., and Kasuga M. A dominant-negative mutant of mSOS1 inhibits insulin-induced ras activation and reveals ras-dependent and -independent insulin signaling pathways. Mol. Cell. Biol. 15 (1995) 379-388
94. Salcini A.E., McGlade J., Pelicci G., Nicoletti I., Pawson T., and Pelicci P.G. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. Oncogene 9 (1994) 2827-2836
95. Scher C.D., Shephard R.C., Antoniades H.N., and Stiles C.D. Platelet derived growth factor and the regulation of the mammalian fibroblasts cell cycles. Biochim. Biophys. Acta 560 (1979) 217-241
96. Schumacher R., Soos M.A., Schlessinger J., Brandenburg D., Siddle K., and Ullrich A. Signaling-competent receptor chimeras allow mapping of major insulin receptor binding domain determinants. J. Biol. Chem. 268 (1993) 1087-1094
97. Sell C., Rubini M., Rubin R., Liu J.-P., Efstratiadis A., and Baserga R. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type-1 IGF receptor. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 11217-11221
98. Sell C., Dumenil G., Deveaud C., Miura M., Coppola D., DeAngelis T., Rubin R., Efstratiadis A., and Baserga R. Effect of a null mutation of the type 1 IGF receptor gene on growth and transformation of mouse embryo fibroblasts. Mol. Cell. Biol. 14 (1994) 3604-3612
99. Sell C., Baserga R., and Rubin R. Insulin-like growth factor (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res. 55 (1995) 303-306
100. Shapiro D.N., Jones B.G., Shapiro L.H., Dias P., and Houghton P.J. Antisense-mediated reduction in insulin-like growth factor 1 receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma. J. Clin. Invest. 94 (1994) 1235-1242
101. Silvennoinen O., Schindler C., Schlessinger J., and Levy D.E. Ras-independent growth factor signaling by transcription factor tyrosin phosphorylation. Science 261 (1993) 1736-1739
102. Smith C.A., Farrah T., and Goodwin R.G. The TNF receptor superfamily of cellular and viral proteins: Activation, co-stimulation and death. Cell 76 (1994) 959-962
103. Steller H. Mechanisms and genes of cellular suicide. Science 267 (1995) 1445-1449
104. Stiles C.D., Capone G.T., Scher C.D., Antoniades N.H., Van Wyk J.J., and Pledger W.J. Dual control of cell growth by somatomedins and platelet derived growth factor. Proc. Natl. Acad. Sci. U.S.A. 76 (1979) 1279-1283
105. Sun X.J., Miralpeix M., Myers M., Glasheen E.M., Backer J.M., Kahn C.R., and White M.F. Expression and function of IRS-1 in insulin signal transmission. J. Biol. Chem. 267 (1992) 22662-22672
106. Surmacz E., Sell C., Swantek J., Kato H., Roberts Jr. C.T., LeRoith D., and Baserga R. Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor I receptor. Exp. Cell Res. 218 (1995) 370-380
107. Takata Y., and Kobayashi M. Insulin-like growth factor I signalling through heterdimers of insulin and insulin-like growth factor I receptors. Diabetes Metab. 20 (1994) 331-336
108. Taouis M., Levy-Toledano R., Roach P., Taylor S.L., and Gorden P. Rescue and activation of a binding-deficient insulin receptor. J. Biol. Chem. 269 (1994) 27762-27766
109. Tavaré J.M., and Siddle K. Mutational analysis of insulin receptor function: consensus and controversy. Biochim. Biophys. Acta 1178 (1993) 21-39
110. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science 267 (1995) 1456-1462
111. Tobe K., Matuoka K., Tamemoto H., Ueki K., Kaburagi Y., Asai S., Noguchi T., Matsuda M., Tanaka S., Hattori S., Fukui Y., Akanuma Y., Yazaki Y., Takenawa T., and Kadowaki T. Insulin stimulates association of insulin receptor substrate-1 with the protein abundant Src homology/growth factor receptor-bound protein 2. J. Biol. Chem. 268 (1993) 11167-11171
112. Trojan J., Johnson T.R., Rudin S.D., Ilan J., Tykocinski M.L., and Ilan I. Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science 256 (1993) 94-97
113. Ullrich A., and Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 61 (1990) 203-212
114. Ullrich A., Gray A., Tam A.W., Yang-Feng T., Tsubokawa M., Collins C., Henzel W., Le Bon T., Kahuria S., Chen E., Jakobs S., Francke U., Ramachandran J., and Fujita-Yamaguchi Y. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 5 (1986) 503-512
115. Vuori K., and Ruoslahti E. Association of insulin receptor substrate-1 with integrins. Science 266 (1994) 1576-1578
116. Wang E. Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl-2 is involved. Cancer Res. 55 (1995) 2284-2292
117. Wang L.M., Myers Jr. M.G., Sun X.J., Aaronson S.A., White M., and Pierce J. IRS-1: Essential for insulin and IL-4-stimulated mitogenesis in hemopoietic cells. Science 261 (1993) 1591-1594
118. Waters S.B., Yamauchi K., and Pessin J.E. Functional expression of insulin receptor substrate-1 is required for insulin-stimulated mitogenic signaling. J. Biol. Chem. 268 (1993) 22231-22234
119. Werner H., Woloschak M., Stannard B., Shen-Orr Z., Roberts C.T., and LeRoith D. The insulin-like growth factor receptor. In: LeRoith D. (Ed). "Insulin-Like Growth Factors: Molecular and Cellular Aspects" (1991), CRC Press, Boca Raton, FL 17-47
120. Werner H., Karnieli E., Rauscher III F.J., and LeRoith D. Wild type and mutant p53 differentially regulate transcription of insulin-like growth factor 1 receptor gene. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 8318-8323
121. White M.F., and Kahn C.R. The insulin signaling system. J. Biol. Chem. 269 (1994) 1-4
122. Whyte M., and Evan G. The last cut is the deepest. Nature (London) 376 (1995) 17-18
123. Yamauchi K., and Pessin J.E. Enhancement or inhibition of insulin signaling by insulin receptor substrate 1 is cell context dependent. Mol. Cell. Biol. 14 (1994) 4427-4434
124. Zhou-Li F., D'Ambrosio C., Li S., Surmacz E., and Baserga R. Association of insulin receptor substrate 1 with simian virus 40 large T antigen. Mol. Cell. Biol. 15 (1995) 4232-4239